{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:39:03Z","timestamp":1720676343000},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jgyn.2012.09.004","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T19:46:05Z","timestamp":1349207165000},"page":"F20-F27","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Ce que les patientes doivent savoir sur le risque osseux et sa pr\u00e9vention"],"prefix":"10.1016","volume":"41","author":[{"given":"F.","family":"Tr\u00e9molli\u00e8res","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2012.09.004_bib0005","first-page":"1069","article-title":"\u00c9tude longitudinale des effets de la m\u00e9nopause sur la perte osseuse en d\u00e9but de m\u00e9nopause","volume":"23","author":"Pouill\u00e8s","year":"1994","journal-title":"Press Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2007.03.019","article-title":"Transmenopausal changes in the trabecular bone structure","volume":"41","author":"Akhter","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0015","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1359\/jbmr.080108","article-title":"In vivo magnetic resonance detects brapid remodeling changes in the topology of the trabecular bone network after menopause and the protective effect of estradiol","volume":"23","author":"Wehrli","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX\u2122 and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0025","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1359\/jbmr.020604","article-title":"Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: The Danish Osteoporosis Prevention Study","volume":"21","author":"Abrahamsen","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00198-005-0027-4","article-title":"The effect of and bone density on the absolute excess, and relative risk o fracture in postmenopausal women aged 50\u201399: results from the National Osteoporosis Risk Assessment (NORA)","volume":"17","author":"Siris","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jbmr.12","article-title":"Prediction of the risk of fracture using BMD and clinical risk factors in early postmenopausal women. Validity of the WHO FRAX model","volume":"25","author":"Tr\u00e9mollieres","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0040","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jbspin.2012.02.014","article-title":"Actualisation 2012\u00a0des recommandations fran\u00e7aises du traitement m\u00e9dicamenteux de l\u2019ost\u00e9oporose post-m\u00e9nopausique","volume":"79","author":"Briot","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0045","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0050","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s001980050100","article-title":"Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study","volume":"8","author":"Garnero","year":"1998","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFFELY study","volume":"15","author":"Garnero","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0060","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Alendronate reduces the risk of vertebral and clinical fractures in women with existing vertebral fractures: results of the fracture intervention trial","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0080","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0100","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","article-title":"Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women","volume":"16","author":"Papapoulos","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0105","first-page":"CD004523","article-title":"Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women","volume":"1","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0110","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.060404","article-title":"Strontium ranelate reduces the risk of vertebral and non vertebral fractures in women eighty years of age and older","volume":"21","author":"Seeman","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0115","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analysis of therapies for postmenopausal osteoporosis. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0125","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on the risk of fracture and bone mineral density. The Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s001980170107","article-title":"Withdrawal of hormone replacement therapy is associated with vertebral bone loss in postmenopausal women","volume":"12","author":"Tr\u00e9mollieres","year":"2001","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0135","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0140","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0145","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2\u00a0trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","article-title":"Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2\u00a0clinical trial","volume":"43","author":"Miller","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0155","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jgyn.2012.09.004_bib0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3\u00a0versus 6years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231512002207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231512002207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:57:12Z","timestamp":1542711432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231512002207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0368231512002207"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2012.09.004","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}